Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2008-02-21 (18 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: AMIENS (80000), Somme
SELARL PHARMACIE PLAQUIN : revenue, balance sheet and financial ratios
SELARL PHARMACIE PLAQUIN is a French company
founded 18 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in AMIENS (80000),
this company of category PME
shows in 2022 a revenue of 4.0 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE PLAQUIN (SIREN 503606162)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
4 048 672 €
N/C
N/C
N/C
N/C
2 220 945 €
2 119 809 €
Net income
214 733 €
179 463 €
180 634 €
142 268 €
150 925 €
86 145 €
41 951 €
124 652 €
67 991 €
EBITDA
N/C
N/C
252 295 €
N/C
N/C
N/C
N/C
192 746 €
126 360 €
Net margin
N/C
N/C
4.5%
N/C
N/C
N/C
N/C
5.6%
3.2%
Revenue and income statement
In 2024, SELARL PHARMACIE PLAQUIN generates positive net income of 215 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 68 k€ -> 215 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
214 733 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 66%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 45%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
65.692%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
45.454%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
326.478
262.937
247.024
207.554
185.307
152.212
118.137
90.919
65.692
Financial autonomy
21.021
24.792
25.908
28.721
31.234
33.509
38.06
40.685
45.454
Repayment capacity
32.884
17.984
None
None
None
None
9.361
None
None
Cash flow / Revenue
3.29%
5.337%
None%
None%
None%
None%
4.416%
None%
None%
Sector positioning
Debt ratio
65.692024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average-8 pts over 3 years
In 2024, the debt ratio of SELARL PHARMACIE PLAQUIN (65.69) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
45.45%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average+7 pts over 3 years
In 2024, the financial autonomy of SELARL PHARMACIE PLAQUIN (45.5%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
9.36 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average
In 2022, the repayment capacity of SELARL PHARMACIE PLAQUIN (9.36) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 105.38. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
118.158
106.915
124.089
101.341
162.902
142.582
125.731
111.31
105.378
Interest coverage
27.834
15.523
None
None
None
None
4.366
None
None
Sector positioning
Liquidity ratio
105.382024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Watch
In 2024, the liquidity ratio of SELARL PHARMACIE PLAQUIN (105.38) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Interest coverage
4.37x2022
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Good
In 2022, the interest coverage of SELARL PHARMACIE PLAQUIN (4.4x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELARL PHARMACIE PLAQUIN
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
297 473 €
308 289 €
0 €
0 €
0 €
0 €
511 671 €
0 €
0 €
Inventory turnover (days)
43
43
0
0
0
0
39
0
0
Customer payment term (days)
9
17
0
0
0
0
10
0
0
Supplier payment term (days)
58
48
0
0
0
0
50
0
0
Positioning of SELARL PHARMACIE PLAQUIN in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SELARL PHARMACIE PLAQUIN is estimated at
2 997 831 €
(range 2 087 642€ - 4 484 927€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
2087k€2997k€4484k€
2 997 831 €Range: 2 087 642€ - 4 484 927€
NAF 5 année 2024
Valuation method used
Net Income Multiple
214 733 €
×
14.0x
=2 997 831 €
Range: 2 087 642€ - 4 484 927€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE PLAQUIN with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE PLAQUIN
What is the revenue of SELARL PHARMACIE PLAQUIN ?
The revenue of SELARL PHARMACIE PLAQUIN in 2022 is 4.0 M€.
Is SELARL PHARMACIE PLAQUIN profitable?
Yes, SELARL PHARMACIE PLAQUIN generated a net profit of 215 k€ in 2024.
Where is the headquarters of SELARL PHARMACIE PLAQUIN ?
The headquarters of SELARL PHARMACIE PLAQUIN is located in AMIENS (80000), in the department Somme.
Where to find the tax return of SELARL PHARMACIE PLAQUIN ?
The tax return of SELARL PHARMACIE PLAQUIN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE PLAQUIN operate?
SELARL PHARMACIE PLAQUIN operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart